AON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation
Leber congenital amaurosis (LCA) is a severe hereditary retinal dystrophy responsible for congenital or early-onset blindness. The most common disease-causing mutation (>10%) is located deep in intron 26 of the CEP290 gene (c.2991+1655A>G). It creates a strong splice donor site that leads to i...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2012-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_4c6ac99f7bf04c2eb9a5d0e5fd83e9c1 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Xavier Gerard |e author |
| 700 | 1 | 0 | |a Isabelle Perrault |e author |
| 700 | 1 | 0 | |a Sylvain Hanein |e author |
| 700 | 1 | 0 | |a Eduardo Silva |e author |
| 700 | 1 | 0 | |a Karine Bigot |e author |
| 700 | 1 | 0 | |a Sabine Defoort-Delhemmes |e author |
| 700 | 1 | 0 | |a Marlèene Rio |e author |
| 700 | 1 | 0 | |a Arnold Munnich |e author |
| 700 | 1 | 0 | |a Daniel Scherman |e author |
| 700 | 1 | 0 | |a Josseline Kaplan |e author |
| 700 | 1 | 0 | |a Antoine Kichler |e author |
| 700 | 1 | 0 | |a Jean-Michel Rozet |e author |
| 245 | 0 | 0 | |a AON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation |
| 260 | |b Elsevier, |c 2012-01-01T00:00:00Z. | ||
| 500 | |a 2162-2531 | ||
| 500 | |a 10.1038/mtna.2012.21 | ||
| 520 | |a Leber congenital amaurosis (LCA) is a severe hereditary retinal dystrophy responsible for congenital or early-onset blindness. The most common disease-causing mutation (>10%) is located deep in intron 26 of the CEP290 gene (c.2991+1655A>G). It creates a strong splice donor site that leads to insertion of a cryptic exon encoding a premature stop codon. In the present study, we show that the use of antisense oligonucleotides (AONs) allow an efficient skipping of the mutant cryptic exon and the restoration of ciliation in fibroblasts of affected patients. These data support the feasibility of an AON-mediated exon skipping strategy to correct the aberrant splicing. | ||
| 546 | |a EN | ||
| 690 | |a antisense oligonucleotide | ||
| 690 | |a CEP290 | ||
| 690 | |a ciliogenesis repair | ||
| 690 | |a LCA | ||
| 690 | |a splice switching-mediated therapy | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Molecular Therapy: Nucleic Acids, Vol 1, Iss C (2012) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2162253116300853 | |
| 787 | 0 | |n https://doaj.org/toc/2162-2531 | |
| 856 | 4 | 1 | |u https://doaj.org/article/4c6ac99f7bf04c2eb9a5d0e5fd83e9c1 |z Connect to this object online. |